Nasdaq Hearings Panel Grants TeamStaff's Request for Continued Listing Subject to a Reverse S...(uture government legislation and regulat...),Health

Date:3/12/2008

uture government legislation and regulation; the loss of key officers and management personnel that could adversely affect our ability to remain competitive; other regulatory and tax developments; and the effect of other important factors disclosed previously and from time-to-time in TeamStaff's filings with the U.S. Securities Exchange Commission. For a discussion of such risks and uncertainties which could cause actual results to differ from those contained in the forward-looking statements, see "Risk Factors" in the Company's Annual Report or Form 10-K for the most recently ended fiscal year. The information in this release should be considered accurate only as of the date of the release. TeamStaff expressly disclaims any current intention to update any forecasts, estimates or other forward-looking statements contained in this press release.

'/>"/>

SOURCE TeamStaff, Inc. Copyright©2008 PR Newswire. All rights reserved

0 GOOD

Page: 1 2 3
Related medicine news :

1. Vion Pharmaceuticals Regains NASDAQ Listing Compliance
2. IDM Pharma Announces Compliance With NASDAQ Minimum Bid Price Requirements
3. Amarin Regains Compliance With Nasdaq Listing Requirements
4. IDM Pharma Receives Notification from NASDAQ Relating to Minimum Bid Price
5. Acura Pharmaceuticals, Inc. Announces Approval to List Shares on NASDAQ and Effective Feb. 4, 2008 a New Trading Symbol: ACUR
6. TeamStaff Receives Nasdaq Determination Letter
7. QMed, Inc. Receives NASDAQ Letter
8. Chindex International, Inc. Announces Transfer to NASDAQ Global Market
9. XCPT(TM) Patient Engagement and Communication Software Signs Representation Agreement with Lifecore Biomedical, Inc. (Nasdaq: LCBM)
10. Elbit Imaging Ltd. Selected for Listing on Nasdaq Global Select Market
11. HEI, Inc. Initiates Delisting and Deregistration of Its Shares on NASDAQ